Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,578 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07035314Recruiting
Comparing medicines for pain after tonsil removal in children
This study compares two ways to manage pain after tonsil removal in children: a medication given by mouth or injection versus a medication applied directly to the surgical site. The goal is to find which approach works better for pain control.
CairoAges 4–10 - NCT07035587Recruiting
A blood test to detect multiple cancers and monitor leftover tumors after treatment
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
SeoulAges 19 years+ - NCT07035886Recruiting
Fruzaqla for metastatic colorectal cancer in South Korea
This study monitors the safety and effectiveness of Fruzaqla (a targeted therapy taken as a pill) in adults with advanced colorectal cancer that has spread to other parts of the body. It is being done in South Korea to gather real-world information about how well the treatment works and how patients respond.
SeoulAges 18 years+ - NCT07035925Recruiting
Testing a hydrogel for treating anal fistulas
This trial tests a hydrogel made from natural materials to help heal a specific type of anal fistula. It may be an option if you have a single high transsphincteric fistula with a seton in place for at least four weeks.
Lebanon, New HampshireAges 18 years+ - NCT07036705Recruiting
Sauna blanket and app for better sleep in insomnia
This study tests whether using a heated sauna blanket before bed, along with a mind-body app, can help adults with insomnia fall asleep faster and sleep better. You would use the blanket at home for a few weeks and answer questions about your sleep.
San Francisco, CaliforniaAges 18 years+ - NCT07036848Recruiting
Surgery for type IVa bile duct cyst
This study tests how well and safely a surgery works for treating a certain type of bile duct cyst (Todani type IVa). It aims to improve outcomes for people who need this operation for the first time.
Beijing, Beijing MunicipalityAges Up to 80 years - NCT07037004RecruitingPhase 2
Testing a gut health supplement with immunotherapy after kidney cancer surgery
This trial is testing whether adding a gut health supplement (CBM588) to the immunotherapy drug pembrolizumab can help prevent kidney cancer from returning after surgery. It is for people with certain types of kidney cancer who have not had immunotherapy before.
Duarte, CaliforniaAges 18 years+ - NCT07037238RecruitingPhase 2
Everolimus for treating vascular malformations
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
BeijingAges 18–65 - NCT07038265Recruiting
Personalized cardiac rehab after a heart attack
This study tests a personalized cardiac rehabilitation program for people who have recently had a heart attack. The program is designed to be more patient-centered, helping you recover and lower your risk for future heart problems.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT07038811Recruiting
App for treating urgent or mixed urinary incontinence
This trial tests a smartphone app called Tät®II to help women with urgency or mixed urinary incontinence. The app may provide exercises and strategies to reduce symptoms without medication or surgery.
ÖstersundAges 18 years+ - NCT07039604Recruiting
Real-world study of PADN for pulmonary artery hypertension
This study tracks how well a procedure called PADN works for people with pulmonary artery hypertension (PAH) in real-life medical settings. PADN is a minimally invasive treatment that targets nerves around the lungs to help lower blood pressure in the arteries.
Nanjing, JiangsuAges Any age - NCT07040072RecruitingPhase 1
Finotonlimab plus Stapokibart for advanced head and neck cancer
This trial tests two drugs, Finotonlimab and Stapokibart, for people with head and neck cancer that has come back or spread to other parts of the body. It may help if you've already tried a PD-1 drug and platinum chemotherapy, but the cancer got worse.
Beijing, Beijing MunicipalityAges 18–75 - NCT07040397Recruiting
Massage therapy study for lower back pain
This study tests whether an electronic approach to massage therapy can help relieve lower back pain. It may be an option if you have persistent lower back pain and haven't used pain medications recently.
Rochester, MinnesotaAges 18 years+ - NCT07041723Recruiting
Online biofeedback for
This study tests an online biofeedback program to help children and teens improve their 's' and 'z' sounds. It might be a good fit if your child struggles with these sounds and meets a few other health and age guidelines.
Bloomfield, New JerseyAges 8–17 - NCT07042451Recruiting
Testing a phone app to support recovery after substance use treatment
This trial is testing whether a smartphone app called Pink Cloud can help people stay in recovery after finishing substance use treatment. You would need to attend one recovery meeting in the next week and use the app on your personal phone.
Los Angeles, CaliforniaAges 18 years+ - NCT07042919RecruitingPhase 1/Phase 2
Zanzalintinib for advanced liver cancer after prior treatment
This trial tests a new drug called zanzalintinib for people with advanced liver cancer (HCC) that can't be treated with surgery. You may join if your cancer has gotten worse after at least one prior treatment, or you couldn't tolerate that treatment.
Chicago, IllinoisAges 18 years+ - NCT07044830Recruiting
Sleep apnea treatment for stroke recovery
This trial tests whether treating sleep apnea with a CPAP machine soon after a stroke can improve recovery. It is for people who had their first moderate-to-severe ischemic stroke and have not used CPAP before.
Ribeirão Preto, São PauloAges 18–80 - NCT07045155RecruitingPhase 4
Study of pegmolesatide for anemia in dialysis patients
This trial tests a new medication, pegmolesatide, to treat anemia in people who have been on dialysis for at least three months. It aims to help improve red blood cell levels without needing as many other anemia treatments.
Beijing, Beijing MunicipalityAges 18–80 - NCT07045896Recruiting
Fucoidan for active rheumatoid arthritis
This trial tests a seaweed extract called fucoidan to see if it can help people with active rheumatoid arthritis that is not well controlled by their current treatments. If you have moderate-to-high disease activity despite therapy, you may be able to join.
BeijingAges 18–65 - NCT07045935RecruitingPhase 4
Metabolic effects of cabergoline in prolactinoma patients
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
BaselAges 18 years+ - NCT07046078RecruitingPhase 2
Chemo, radiation, and donor transplant for older adults with high-risk AML
This trial tests a combination of chemotherapy (FLAG-Ida) followed by low-dose total body radiation and a stem cell transplant from a donor. It is for people age 60 and older with newly diagnosed high-risk blood cancers, aiming to improve outcomes with a less intense transplant preparative regimen.
Seattle, WashingtonAges 18 years+ - NCT07046546Recruiting
Thyroid nodule embolization pilot trial
This trial tests a minimally invasive procedure that blocks blood flow to large thyroid nodules, which can shrink them and relieve symptoms like trouble swallowing or cosmetic concerns. It's an option for people with benign nodules or Graves disease who want to avoid surgery or other treatments.
ReadingAges 18 years+ - NCT07046806RecruitingPhase 1/Phase 2
Oral deucrictibant for hereditary angioedema attacks
This trial tests an oral medication called deucrictibant to prevent and treat swelling attacks in people with hereditary angioedema. It may help reduce the number and severity of attacks.
Wheaton, MarylandAges 18–75 - NCT07046884Recruiting
Personalized Cancer Treatment Decisions Study
This study tests a new way to help you and your doctor choose the best cancer treatment together. If you are 18 or older, in a participating hospital's oncology program, and have not yet made a treatment decision, this trial may be a good fit.
GroningenAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,578 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.